论文部分内容阅读
2013年12月5日下午,安捷伦科技公司与云泰集团的战略合作新闻发布会在上海锦江饭店内进行,安捷伦全球高级副总裁、生命科学与诊断事业部总裁Lars Holmkvist先生、云泰集团CEO熊慧女士,双方高层及媒体和用户代表共同出席了此次新闻发布会。会上,双方联合宣布结为战略合作伙伴,借助双方优势,共同致力于血液病和癌症疾病的分子诊疗产品的开发,为推动国内生物医药产业的发展做出贡献。之后,安捷伦副总裁Lars先生与云泰集团总裁郁涵
On the afternoon of December 5, 2013, a press briefing by Agilent Technologies and YUNTAI on strategic cooperation was held in Shanghai Jin Jiang Hotel. Lars Holmkvist, Senior Vice President, President, Life Sciences and Diagnostics, Agilent Technologies, Ms. Hui, both sides of the top and the media and user representatives attended the press conference. At the meeting, the two sides jointly announced the formation of a strategic partner, with the help of both parties, jointly committed to the development of molecular diagnostics products for hematological diseases and cancer diseases and contributed to the development of the domestic biomedical industry. After that, Mr. Lars, vice president of Agilent and Yu-han Group President Yu Han